Harpreet Singh, MD

Harpreet Singh, MD, is Chief Medical Officer at Precision for Medicine, leading biomarker driven clinical development in oncology and rare diseases. Previously Director of the FDA’s Division of Oncology, she is known for advancing precision medicine and innovative trial design. A trained medical oncologist, she completed medical training at USC and a fellowship at the NCI.

Articles by Harpreet Singh, MD

Harpreet Singh, MD, chief medical officer at Precision for Medicine and former FDA Oncology Division Director,

What Does the Regulatory Landscape Look Like From the Other Side of FDA?

ByNicholas Jacobus,Harpreet Singh, MD

May 21st 2026

Harpreet Singh, MD, says understanding regulatory precedent, division-level dynamics, and the agency’s data-driven culture is critical for biopharma sponsors navigating today’s oncology approval landscape.

Harpreet Singh, MD

Articles by Harpreet Singh, MD

What Does the Regulatory Landscape Look Like From the Other Side of FDA?

Latest Updated Articles

Trending on PharmExec

The Industry’s Communication and Engagement with FDA

Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio

Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration

Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio

The Difference Between Real-Time Clinical Data Review and Real-Time Clinical Trial Oversight